Processa Pharmaceuticals, Inc.

PCSACIK 0001533743 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0040

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Apr 30, 2026no items parsed Feb 19, 2026no items parsed Jan 7, 2026no items parsed Dec 15, 2025no items parsed Sep 16, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Processa Pharmaceuticals, Inc.

Name	Roles	Filings
Young David	OfficerDirector10% Owner	28
Lin Patrick	Officer	26
Guy Wendy	Officer	19
Bigora Sian	Officer	17
Ng George K	OfficerDirector	17

Showing 1-5 of 14

Per pagePage 1 of 3Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Processa Pharmaceuticals, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Yorke Justin W	3	33%	-21.5%	-22.2%	+19.3%	-61.6%
2	Young David	8	50%	-11.1%	+1.5%	+15.0%	-61.6%
3	Lin Patrick	7	14%	-4.5%	-7.9%	+72.5%	-61.6%

All filings

180 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 17, 2026	Skibsted Russell Chief Financial Officer	PPurchase	1,984	$2.97	$5,892
Apr 17, 2026	Bigora Sian Chief Development Officer	PPurchase	1,799	$2.97	$5,343
Apr 17, 2026	Guy Wendy Chief Administrative Officer	PPurchase	1,583	$2.97	$4,702
Apr 17, 2026	Lin Patrick Chief Business - Strategy Off	PPurchase	1,369	$2.97	$4,066
Apr 17, 2026	Ng George K Chief Executive Officer · Director	PPurchase	1,843	$2.97	$5,474

Showing 21-25 of 180

Per pagePrevPage 5 of 36Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value